Searched for
AJANTA PHARMA RESULTS
PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ajanta Pharma buyback: Last day today to buy shares for Rs 285 crore special situation opportunityAjanta Pharma has set May 30 as the record date for its Rs 285 crore share buyback,. The buyback, at a premium of 12.6%, targets 10,28,881 ...
- Ajanta Pharma shares jump over 13% on strong Q4 results, buyback plansAjanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (Y...
- Ajanta Pharma Q4 Results: Net profit soars 66% YoY to Rs 203 crRevenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta P...
- This smallcap pharma company declares 350% interim dividend; record date fixedPayment of interim dividend of Rs 7/- (350%) per equity share on the face-value of Rs 2/- per share for the Financial Year 2022-23,” said t...
- Ajanta Pharma Q4 Results: Net profit falls 5% to Rs 151 crFor the year ended March 31, 2022, the company posted a PAT of Rs 713 crore. It was Rs 654 crore in FY21. Revenue from operations rose to R...
- Ajanta Pharma Q3 Results: Net profit up 9% at Rs 192 croreDuring the period under review, the drug maker reported sales of Rs 256 crore in the domestic market, compared to Rs 220 crore earlier.
- Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
- Ajanta Pharma Q3 results: Net profit rises 64% to Rs 177 crThe company had posted a net profit of Rs 108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.
- Ajanta Pharma Q1 results: Profit up 29% at Rs 148 croreAjanta Pharma on Thursday reported 28.90 per cent rise in consolidated net profit to Rs 147.76 crore for the quarter ended June 30, 2020.
- Buy Ajanta Pharma, target price Rs 1,880: EdelweissThe brokerage estimates earnings to expand at a 19% CAGR over FY20–22, led by 11% top-line CAGR and 250 bps margin expansion.
- Ajanta Pharma Q3 profit dips 55% to Rs 67 croreConsolidated revenue from operations of the company stood at Rs 485.11 crore for the quarter.
- HC allows Indian firm to export drug in which Bayer has patentBayer admitted before the court that it has not used its patents for commercial exploitation in India while Ajanta had launched its drug ba...
- Ajanta Pharma slips over 14% on USFDA import alertAjanta Pharma was trading 4.35 per cent lower at Rs 1,706 in early trade around 10.30 am (IST) on BSE.
- Ajanta Pharma Q1 net up 80 per cent at Rs 58.72 croreShares of Ajanta Pharma were trading at Rs 1,590.75 per scrip in the afternoon trade on BSE, down 8.60% from the previous close.
- Ajanta Pharma rallies 20% post Q3 resultsThe company posted a net profit of Rs 32.6 crore for the quarter, up 76 per cent, compared to a net profit of Rs 18.5 crore in the same per...
Load More
